Equity Holdings of Nippon India Pharma Fund
Here is the most recent list of
equity holdings in the Nippon India Pharma Fund's portfolio
as of 31 Oct 2025 . The fund's AUM is 6,891.31 crores, of which equity holdings constitute 99.67%.
| Name of the Equity | Holding Percentage |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | 12.67% |
| DIVI'S LABORATORIES LTD. | 8.07% |
| LUPIN LTD. | 7.26% |
| CIPLA LTD. | 6.29% |
| APOLLO HOSPITALS ENTERPRISE LTD. | 5.97% |
| Vijaya Diagnostic Centre Ltd | 3.42% |
| Medplus Health Services Ltd | 3.32% |
| Gland Pharma Ltd | 3.05% |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD. | 2.87% |
| AJANTA PHARMA LTD. | 2.83% |
| Thyrocare Technologies Ltd | 2.59% |
| ABBOTT INDIA LTD. | 2.39% |
| AUROBINDO PHARMA LTD. | 2.32% |
| Dr. Lal PathLabs Ltd | 2.29% |
| Alkem Laboratories Ltd | 2.14% |
| BIOCON LTD. | 2.10% |
| PFIZER LTD. | 1.99% |
| Narayana Hrudayalaya Ltd | 1.95% |
| IPCA LABORATORIES LTD. | 1.50% |
| FORTIS HEALTHCARE LTD. | 1.35% |
| Sanofi India Ltd | 1.32% |
| Max Healthcare Institute Ltd | 1.23% |
| Syngene International Ltd | 1.00% |
| ASTRAZENECA PHARMA INDIA LTD. | 0.72% |
| INDOCO REMEDIES LTD. | 0.61% |
| Orchid Pharma Ltd | 0.43% |